Capital Markets Union: What Will It Take to Be a Sucess
Journal of Financial Supervisors Academy · 01.09.2025 · 1
DOI: 10.64443/jfsa.2025.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Financial Supervisors Academy, online erschienen am 01.09.2025. Verfasst von Pierre-Henri Conac.
Abstract (Originalsprache)
The Capital Markets Union (CMU) was launched in July 2014 by the European Commission as a project to harmonise the rules applicable to the financial sector. The CMU is a continuation of the De Larosière report of February 2009, which advocated “central regulation – local supervision” for the financial industry (banking, securities, insurance). This approach relied on the adoption of a Single Rule Book (SRB) to ensure that the same rules are applicable throughout the single market and on the creation of a European Securities and Markets Authority (ESMA). Critics have recently expressed the view that the SRB has not led to a sufficient flow of cross-border transactions. It is true that the current situation does not always ensure a completely harmonised SRB and supervisory convergence. However, centralisation of supervision, as advocated, will not, per se, make the CMU a success. It might not even be effective. Rather, incremental technical changes can achieve a much stronger single rulebook and supervisory level-playing field. Therefore, the goal of the new legislative action on the CMU should be to adopt targeted technical changes to increase cross-border activities.
Zitieren
APA
Conac, P. (2025). Capital Markets Union: What Will It Take to Be a Sucess. Journal of Financial Supervisors Academy, 1. https://doi.org/10.64443/jfsa.2025.007
Vancouver
Conac P. Capital Markets Union: What Will It Take to Be a Sucess. Journal of Financial Supervisors Academy. 2025;1. doi:10.64443/jfsa.2025.007
BibTeX
@article{Conac2025,
author = {Conac, Pierre-Henri},
title = {Capital Markets Union: What Will It Take to Be a Sucess},
journal = {Journal of Financial Supervisors Academy},
year = {2025},
volume = {1},
doi = {10.64443/jfsa.2025.007}
}
EUVIMED